| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.14 | 0.008 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.008 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.089 | 0.009 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.009 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.086 | 0.009 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.009 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.093 | 0.01 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |